TNF and COVID-19: The proinflammatory and fibrosis-driving pathway, such as tumor necrosis factor-alpha (TNFα), transforming growth factor beta (TGFβ), nuclear factor κB (NFκB), and JAK-STAT, shows higher activity in COVID-19 patients